Articles tagged "Parkinson’s"

2022 International Congress
Neural and cognitive correlates of the co-occurrence of apathy and Impulse Control Disorder in early Parkinson’s Disease
G. Maggi, S. Costa, F. Loayza, G. Santangelo, I. Obeso (Caserta, Italy)
Objective: The present study aims to explore the co-occurrence of impulse control disorder (ICD) and apathy and its neural correlates analyzing anatomical changes in gray…
2022 International Congress
Anatomical Substrates for Motor Subcomponents of Bradykinesia in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Simulation
MJ. Kim, Y. Shi, Y. Salimpour, WS. Anderson, K. Mills (Baltimore, USA)
Objective: To evaluate distinct anatomical substrates modulating motor subcomponents of bradykinesia following Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD). Background: PD…
2022 International Congress
WATCH-PD: Baseline Phenotype and Longitudinal Digital Assessments in Early PD
T. Kangarloo, E. Dorsey, P. Auinger, D. Volfson, J. Padmanabhan, B. Tracey, RS. Latzman, P. Artoni, Y. Gong, A. Best, J. Severson, D. Anderson, M. Kostrzebski, A. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Praneeth Kilambi, J. Edgerton, J. Adams (Cambridge, USA)
Objective: To provide a longitudinal profile of early Parkinson’s (PD) disease progression using clinical and digital measures, and to evaluate the extent to which digital…
2022 International Congress
Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug
C. Gonzalez-Robles, D. Byrom, R. Chapman, D. Dexter, S. Duty, R. Ellis-Doyle, E. Jabbari, G. Mills, H. Mortiboys, J. Rudiger, E. Sammler, P. Scurfield, S. Stott, G. Tofaris, L. Wei, A. Wong, ML. Zeissler, C. Carroll, T. Foltynie, O. Bandmann, A. Schapira (London, United Kingdom)
Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatments for…
2022 International Congress
Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline
E. Brown, M. San Luciano, S. Goldman, M. Korell, B. Contreras, C. Tanner (San Francisco, USA)
Objective: To compare rates of self-reported cognitive and motor decline in people with Parkinson’s Disease (PD) with and without a history of head injury (HI).…
2022 International Congress
Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research
K. Schroeder, C. Gallagher, M. Armstrong, M. Carnie, C. Evers, J. Fleisher, B. Kluger, J. Lamb, S. Seshadri, L. Wilson, M. Feeney, P. Davies (New York, USA)
Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…
2022 International Congress
Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia
C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)
Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
2022 International Congress
An accurate yet practical method for DBS battery life prediction
S. Jinks (Sacramento, USA)
Objective: To develop a simple, accurate algorithm for predicting DBS IPG battery life in patients with PD, ET and dystonia. Background: Battery life for DBS…
2022 International Congress
Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.
GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)
Objective: To describe the association amongst depression, anxiety, psychosis with cognitive impairment in Mexican people living with Parkinson’s disease (PwP). Background: Cognitive impairment and neuropsychiatric…
2022 International Congress
PD GENEration Clinical Phase: Genetic Diagnostic Yield and Clinical Characteristics
L. Cook, J. Verbrugge, T. Schwantes-An, M. Nance, A. Naito, K. Marder, M. Schwarzschild, T. Simuni, A. Wills, A. Hall, J. Schulze, P. Hodges, C. Casaceli, L. Heathers, K. Ghosh, J. Beck, R. Alcalay (Indianapolis, USA)
Objective: To assess the frequency of reportable variants in major genes associated with Parkinson’s disease (PD) and identify clinical predictors of positive genetic test results.…